Evidence map›Paper›PMID 37133700›Full record

ArticleClinical oral investigations2023

Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis.

Camilo Castellar-Mendoza, Diana Marcela Castillo, Lorena Chila-Moreno, Wilson Bautista-Molano, Consuelo Romero-Sánchez

Open access · hybridAbstract read
In one paragraph

Article in Clinical oral investigations, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Pathogenesis ofFrontiers in cellular and infection microbiology · 2026
    Review
  2. Virulence · 2025
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Camilo Castellar-MendozaMaster's Program in Basic Biomedical Sciences, Universidad El Bosque, Bogotá, Colombia.ORCID https://orcid.org/0000-0003-2811-0626
Diana Marcela CastilloOral Basic Research Unit (UIBO), Research Vice-Rectory, School of Dentistry, Universidad El Bosque, Av. Carrera 9 #131A-02, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-1846-7448
Lorena Chila-MorenoSchool of Dentistry, INMUBO Cellular and Molecular Immunology Group, Universidad El Bosque, Av. Carrera 9 #131A-02, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-1911-2892
Wilson Bautista-MolanoSchool of Dentistry, INMUBO Cellular and Molecular Immunology Group, Universidad El Bosque, Av. Carrera 9 #131A-02, Bogotá, Colombia.ORCID https://orcid.org/0000-0003-0684-9542
Consuelo Romero-SánchezSchool of Dentistry, INMUBO Cellular and Molecular Immunology Group, Universidad El Bosque, Av. Carrera 9 #131A-02, Bogotá, Colombia. romeromaria@unbosque.edu.co.ORCID https://orcid.org/0000-0002-6973-7639
Universidad El Bosque · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPorphyromonas gulae have the enzyme PPAD, as P. gingivalis, which is responsible for citrullination related to the pathophysiology of rheumatoid arthritis and periodontitis; this implies the presence of two species of PPAD-producing bacteria in the mouth as well as the presence of citrullinated proteins. There are no previous reports or studies investigating an association between P. gulae PPAD in rheumatoid arthritis (RA).

objectiveTo assess the presence of P. gulae and anti-citrullinated peptide antibodies of P. gulae PAD in patients with RA and their possible relationship with clinical activity markers. SUBJECTS AND

methodsA total of 95 patients with RA and 95 controls were included. Erythrocyte sedimentation rate (ESR), C-reactive protein, anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) were measured. Activity index-28 (DAS28) and SCDAI. The periodontal diagnosis was established. Presence of P. gulae and P. gingivalis. An ELISA was used to determine antibodies against citrullinated peptides of P. gulae PAD.

resultsA P. gulae frequency of 15.8% was observed in the RA group and 9.5% in the control group. Higher levels of ACPA were found in the P. gulae-positive patients of the RA group, finding no significant difference, but if in patients positive for P. gingivalis with statistical significance (p = 0.0001). The frequency of anti-VDK-cit and anti-LPQ-cit9 antibodies to PPAD of P. gulae was higher in the RA group than in the control group without significant difference. No relationship was found with the clinical variables despite the presence of P. gulae and anti-citrullinated peptide antibodies of P. gulae PPAD in patients with RA

conclusionsIt was not possible to establish a connection with clinical variables in RA and P. gulae; as a result, the presence of P. gingivalis continues to contribute significantly to the increase in antibodies against citrullinated proteins/peptides from exogenous sources of citrullination in RA and periodontitis.

Indexed as

Arthritis, RheumatoidPeriodontitisAnti-Citrullinated Protein AntibodiesCitrullinationHumansPeptidesPorphyromonasPorphyromonas gingivalisProtein-Arginine DeiminasesAnti-Citrullinated Protein AntibodiesPeptidesProtein-Arginine DeiminasesAntibodiesBacteriaImmunologyPeriodontitisPeriodontiumPorphyromonas gulaeRheumatoid arthritisRheumatology

Identifiers

PMID37133700
PMCPMC10329627
OpenAlexW4367835021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.